Research Topics
Genomes and Genes
| S CorySummaryAffiliation: The Walter and Eliza Hall Institute of Medical Research Country: Australia Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Suzanne CoryCarina Dennis
Nat Med 8:203. 2002
The Bcl2 family: regulators of the cellular life-or-death switchSuzanne Cory
The Walter and Eliza Hall Institute of Medical Research, PO Royal Melbourne Hospital, Victoria 3050, Australia
Nat Rev Cancer 2:647-56. 2002..Apoptosis is often impaired in cancer and can limit conventional therapy. A better understanding of how the Bcl2 family controls caspase activation should result in new, more effective therapeutic approaches...
The Bcl-2 family: roles in cell survival and oncogenesisSuzanne Cory
The Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville 3050, Victoria, Australia
Oncogene 22:8590-607. 2003..Finally, it discusses the promise of novel anticancer therapeutics that target these vital regulators...
Killing cancer cells by flipping the Bcl-2/Bax switchSuzanne Cory
The Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, Victoria 3050, Australia
Cancer Cell 8:5-6. 2005..Hence, this work validates Bcl-2-like proteins as important new targets in cancer therapy...
Matters of life and death: programmed cell death at Cold Spring HarborS Cory
Walter and Eliza Hall Institute of Medical Research, PO Royal Melbourne Hospital, Victoria, Australia
Biochim Biophys Acta 1377:R25-44. 1998
Survival activity of Bcl-2 homologs Bcl-w and A1 only partially correlates with their ability to bind pro-apoptotic family membersS P Holmgreen
The Walter and Eliza Hall Institute of Medical Research, PO Royal Melbourne Hospital Victoria 3050, Australia
Cell Death Differ 6:525-32. 1999..The results may reflect critical threshold affinities but also suggest that certain pro-apoptotic proteins may also contribute to apoptosis by a mechanism independent of binding pro-survival proteins...
Progenitor tumours from Emu-bcl-2-myc transgenic mice have lymphomyeloid differentiation potential and reveal developmental differences in cell survivalA Strasser
The Walter and Eliza Hall Institute of Medical Research, PO Royal Melbourne Hospital, Melbourne, Australia 3050
EMBO J 15:3823-34. 1996..These results provide insight into the process of lineage commitment and suggest new levels of control of cell survival during early steps in haemopoietic development...
Bim: a novel member of the Bcl-2 family that promotes apoptosisL O'Connor
The Walter and Eliza Hall Institute of Medical Research, PO Royal Melbourne Hospital, Victoria, Australia
EMBO J 17:384-95. 1998..Hence, Bim appears to act as a 'death ligand' which can only neutralize certain members of the pro-survival Bcl-2 sub-family...
Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosisA Strasser
Walter and Eliza Hall Institute of Medical Research, Royal Melbourne Hospital, Victoria, Australia
EMBO J 14:6136-47. 1995..These data raise the possibility that Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis...
Degenerative disorders caused by Bcl-2 deficiency prevented by loss of its BH3-only antagonist BimP Bouillet
The Walter and Eliza Hall Institute of Medical Research, P O Royal Melbourne Hospital, Victoria 3050, Melbourne, Australia
Dev Cell 1:645-53. 2001..These results demonstrate that Bim levels set the threshold for initiation of apoptosis in several tissues and suggest that degenerative diseases might be alleviated by blocking BH3-only proteins...
Bcl-2 expression promotes B- but not T-lymphoid development in scid miceA Strasser
Walter and Eliza Hall Institute of Medical Research, Royal Melbourne Hospital, Victoria, Australia
Nature 368:457-60. 1994....
Positive and negative selection of T cells in T-cell receptor transgenic mice expressing a bcl-2 transgeneA Strasser
Walter and Eliza Hall Institute of Medical Research, P O Royal Melbourne Hospital, Victoria, Australia
Proc Natl Acad Sci U S A 91:1376-80. 1994..Thus, although bcl-2 expression hampers the deletion of immature self-reactive cells in the thymus, self-tolerance is maintained...
Life-or-death decisions by the Bcl-2 protein familyJ M Adams
The Walter and Eliza Hall Institute of Medical Research, P O Royal Melbourne Hospital, 3050, Melbourne, Australia
Trends Biochem Sci 26:61-6. 2001..Pro-apoptotic family members act as sentinels for cellular damage: cytotoxic signals induce their translocation to the organelles where they bind to their pro-survival relatives, promote organelle damage and trigger apoptosis...
Transgenic models of lymphoid neoplasia and development of a pan-hematopoietic vectorJ M Adams
The Walter and Eliza Hall Institute of Medical Research, P O Royal Melbourne Hospital, Melbourne, Victoria 3050, Australia
Oncogene 18:5268-77. 1999..This novel vector should aid studies on many aspects of hematopoiesis, including the modeling of leukemogenesis...
bcl-2 transgene inhibits T cell death and perturbs thymic self-censorshipA Strasser
Walter and Eliza Hall Institute of Medical Research, Royal Melbourne Hospital Post Office, Victoria, Australia
Cell 67:889-99. 1991..These observations, together with previous findings on B cells, suggest that modulated bcl-2 expression is a determinant of life and death in normal lymphocytes...
Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2A Strasser
Walter and Eliza Hall Institute of Medical Research, Royal Melbourne Hospital, Victoria, Australia
Nature 348:331-3. 1990..Suprisingly, the tumours derive from a cell with the hallmarks of a primitive haemopoietic cell, perhaps a lymphoid-committed stem cell...
Acceleration of B-lymphoid tumorigenesis in E mu-myc transgenic mice by v-H-ras and v-raf but not v-ablW Y Langdon
Walter and Eliza Hall Institute of Medical Research, Royal Melbourne Hospital, Australia
Oncogene Res 4:253-8. 1989..These results imply that v-H-ras and v-raf synergize with deregulated myc expression to transform pre-B cells, while v-abl apparently does not...
Insights from transgenic mice regarding the role of bcl-2 in normal and neoplastic lymphoid cellsS Cory
Walter and Eliza Hall Institute of Medical Research, Royal Melbourne Hospital, Victoria, Australia
Philos Trans R Soc Lond B Biol Sci 345:289-95. 1994..Crosses of the bcl-2 transgenic mice with p53-/- mice have addressed whether loss of p53 function and gain of bcl-2 function are synergistic for lymphoid cell survival...
Immunoglobulin JH rearrangement in a T-cell line reflects fusion to the DH locus at a sequence lacking the nonamer recognition signalS Gerondakis
Walter and Eliza Hall Institute of Medical Research, Royal Melbourne Hospital, Victoria, Australia
Immunogenetics 28:255-9. 1988..This result suggests that the heptamer may be the primary determinant of the specificity in V-gene assembly and that the DH locus as a whole may be preferred target for recombination...
Transformation of bone marrow cells from E mu-myc transgenic mice by Abelson murine leukemia virus and Harvey murine sarcoma virusD Dyall-Smith
Ludwig Institute for Cancer Research, Victoria, Australia
Oncogene Res 2:403-9. 1988..Thus expression of a deregulated c-myc gene together with either v-Ha-ras or v-abl does not ensure fully autonomous growth of early B lymphoid cells...
bcl-w, a novel member of the bcl-2 family, promotes cell survivalL Gibson
Walter and Eliza Hall Institute of Medical Research, PO Royal Melbourne Hospital, Victoria, Australia
Oncogene 13:665-75. 1996..These findings suggest that bcl-w participates in the control of apoptosis in multiple cell types. Its functional similarity to bcl-2 also makes it an attractive candidate proto-oncogene...
An E mu-v-abl transgene elicits plasmacytomas in concert with an activated myc geneH Rosenbaum
Walter and Eliza Hall Institute of Medical Research, Royal Melbourne Hospital, Victoria, Australia
EMBO J 9:897-905. 1990..Moreover, progeny of a cross with analogous E mu-myc mice rapidly developed oligoclonal plasmacytomas. Thus, the collusion of v-abl with c-myc is stage specific, efficiently transforming plasma cells but not pre-B cells or B cells...
Subversion of the Bcl-2 life/death switch in cancer development and therapyJ M Adams
The Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia
Cold Spring Harb Symp Quant Biol 70:469-77. 2005..We find that, like Bad, ABT-737 kills cells efficiently only if Mcl-1 is absent or down-regulated. Thus, manipulation of apoptosis by targeting the Bcl-2 family has exciting potential for cancer treatment...
The conserved N-terminal BH4 domain of Bcl-2 homologues is essential for inhibition of apoptosis and interaction with CED-4D C Huang
The Walter and Eliza Hall Institute of Medical Research, Post Office Royal Melbourne Hospital, Victoria, Australia
EMBO J 17:1029-39. 1998..These results favour the hypothesis that the BH4 domain of pro-survival Bcl-2 family members allows them to sequester CED-4 relatives and thereby prevent apoptosis...
Apoptosis regulator bcl-w is essential for spermatogenesis but appears otherwise redundantC G Print
The Walter and Eliza Hall Institute of Medical Research, Post Office, Royal Melbourne Hospital, Victoria 3050, Australia
Proc Natl Acad Sci U S A 95:12424-31. 1998..The bcl-w-/- mouse provides a unique model of failed spermatogenesis in the adult that may be relevant to some cases of human male sterility...
The Bcl-2 apoptotic switch in cancer development and therapyJ M Adams
Department of Molecular Genetics of Cancer, The Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, Victoria 3050, Australia
Oncogene 26:1324-37. 2007..Better understanding of the Bcl-2 family is clarifying its role in cancer development, revealing how conventional therapy works and stimulating the search for "BH3 mimetics" as a novel class of anticancer drugs...
Regulation of lymphocyte survival by the bcl-2 gene familyS Cory
Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia
Annu Rev Immunol 13:513-43. 1995..Expression in tumors of bcl-2 and other cell survival genes may constitute a major barrier to the success of genotoxic cancer therapy...
Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune diseaseA Strasser
Walter and Eliza Hall Institute of Medical Research, Royal Melbourne Hospital, Victoria, Australia
Proc Natl Acad Sci U S A 88:8661-5. 1991..Thus E mu-bcl-2-22 mice constitute a transgenic model for a systemic autoimmune disease resembling the human disorder systemic lupus erythematosus...
The role of bim, a proapoptotic BH3-only member of the Bcl-2 family in cell-death controlA Strasser
Walter and Eliza Hall Institute, Post Office Royal Melbourne Hospital, 3050 Vic, Melbourne, Australia
Ann N Y Acad Sci 917:541-8. 2000..Unleashed BH3-only proteins neutralize the prosurvival function of Bcl-2-like molecules, and this is thought to liberate Apaf-l-like adapters to activate caspase zymogens, which then initiate cell degradation...
The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralizedMark F van Delft
The Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, Victoria 3050, Australia
Cancer Cell 10:389-99. 2006..Hence, ABT-737 should prove efficacious in tumors with low Mcl-1 levels, or when combined with agents that inactivate Mcl-1, even to treat those tumors that overexpress Bcl-2...
Bcl-2-regulated apoptosis: mechanism and therapeutic potentialJerry M Adams
The Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Melbourne 3050 Australia
Curr Opin Immunol 19:488-96. 2007..The Bcl-2 family may also regulate autophagy and mitochondrial fission/fusion. Its pro-survival members are attractive therapeutic targets in cancer and perhaps autoimmunity and viral infections...
In vivo efficacy of the Bcl-2 antagonist ABT-737 against aggressive Myc-driven lymphomasKylie D Mason
The Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria 3050, Australia
Proc Natl Acad Sci U S A 105:17961-6. 2008..Our data suggest that antagonism of Bcl-2 with small organic compounds is an attractive approach to enhance the efficacy of conventional therapy for the treatment of Myc-driven lymphomas that over-express this prosurvival molecule...
Apoptosomes: engines for caspase activationJerry M Adams
The Walter and Eliza Hall Institute of Medical Research, Melbourne, 3050, Victoria, Australia
Curr Opin Cell Biol 14:715-20. 2002..CED-4 is essential for apoptosis in the worm and Dark for many apoptotic responses in the fly, but the Apaf-1/caspase-9 system probably amplifies rather than initiates the mammalian caspase cascade...
Elevated Mcl-1 perturbs lymphopoiesis, promotes transformation of hematopoietic stem/progenitor cells, and enhances drug resistanceKirsteen J Campbell
Molecular Genetics of CancerDivision, Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville 3052, Victoria, Australia
Blood 116:3197-207. 2010..Collectively, these results demonstrate that Mcl-1 overexpression renders hematopoietic cells refractory to many cytotoxic insults, perturbs lymphopoiesis and promotes malignant transformation of hematopoietic stem and progenitor cells...
Elevated Mcl-1 inhibits thymocyte apoptosis and alters thymic selectionK J Campbell
The Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Melbourne, Victoria 3052, Australia
Cell Death Differ 19:1962-71. 2012....
Conditional immortalization of mouse myelomonocytic, megakaryocytic and mast cell progenitors by the Hox-2.4 homeobox geneA C Perkins
Walter and Eliza Hall Institute of Medical Research, Australia
EMBO J 12:3835-46. 1993..Thus ectopic expression of Hox-2.4 enhances self-renewal of immature myeloid progenitors and progression to a fully malignant state is favoured by somatic mutations conferring autocrine production of IL-3...
BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytesPhilippe Bouillet
The Walter and Eliza Hall Institute of Medical Research, Melbourne, P O The Royal Melbourne Hospital, Victoria 3050, Australia
Nature 415:922-6. 2002..TCR ligation upregulated Bim expression and promoted interaction of Bim with Bcl-XL, inhibiting its survival function. These findings identify Bim as an essential initiator of apoptosis in thymocyte-negative selection...
MYC levels govern hematopoietic tumor type and latency in transgenic miceDarrin P Smith
The Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia
Blood 108:653-61. 2006..The implication is that MYC level affects the spontaneous acquisition of synergistic oncogenic mutations...
Bim is a suppressor of Myc-induced mouse B cell leukemiaAlexander Egle
The Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Melbourne, Victoria 3050, Australia
Proc Natl Acad Sci U S A 101:6164-9. 2004..Whereas the p19Arf/p53 pathway is frequently mutated in tumors arising in Bim(+/+) Emicro-Myc mice, it was unaffected in most Bim-deficient tumors, indicating that Bim reduction is an effective alternative to loss of p53 function...
VavP-Bcl2 transgenic mice develop follicular lymphoma preceded by germinal center hyperplasiaAlexander Egle
Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia
Blood 103:2276-83. 2004..We suggest that the increased survival capacity of B and T cells fosters prolonged germinal center reactions, and that autoreactivity and hypermutation conspire to generate follicular lymphoma...
Research Grants
- ONCOGENE INDUCED LEUKEMOGENESIS IN TRANSGENIC MICESuzanne Cory; Fiscal Year: 2004....
- ONCOGENE INDUCED LEUKEMOGENESIS IN TRANGENIC MICESuzanne Cory; Fiscal Year: 2007..abstract_text> ..
- ONCOGENE-INDUCED LEUKEMOGENESIS IN TRANSGENIC MICESuzanne Cory; Fiscal Year: 1993..The results will be directly relevant to many human lymphomas and leukemias and have wide ramifications for malignancy in general...
- ONCOGENE INDUCED LEUKEMOGENESIS IN TRANSGENIC MICESuzanne Cory; Fiscal Year: 1999....
- ONCOGENE INDUCED LEUKEMOGENESIS IN TRANGENIC MICESuzanne Cory; Fiscal Year: 2009..abstract_text> ..
